What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content
Your Unread Messages in Rheumatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
Smartest Doc Challenge
MDLinx
Pediatric and Adolescent Sports Injury Clinical Pearls
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Mirtazapine effective in treating fibromyalgia
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
261 Type I interferons in Sjogrens syndrome Autoimmunity Reviews, March 14, 2013 Review Article
262 [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis Rheumatology, March 14, 2013 Clinical Article
263 Perspectives on epigenetic based immune intervention for rheumatic diseases Arthritis Research & Therapy, March 14, 2013 Clinical Article
264 A comparison of clinician-rated neuropsychological and self-rated cognitive assessments in patients with asthma and rheumatologic disorders Allergy and Asthma Proceedings, March 14, 2013 Review Article
265 Laryngeal involvement in Behcets disease--a challenge for treatment Clinical Rheumatology, March 14, 2013
266 Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjogrens syndrome Modern Rheumatology, March 14, 2013 Clinical Article
267 Discoid Lupus Alopecia Complicated by Frontal Fibrosing Alopecia on a Background of AGA British Journal of Dermatology, March 14, 2013 Review Article
268 A case of adult-onset Stills disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema Modern Rheumatology, March 14, 2013
269 Ganghwaljetongyeum, an anti-arthritic remedy, attenuates synoviocyte proliferation and reduces the production of proinflammatory mediators in macrophages: The therapeutic effect of GHJTY on rheumatoid arthritis Full Text BMC Complementary and Alternative Medicine, March 13, 2013 Clinical Article
270 Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis Clinical Rheumatology, March 13, 2013
271 Association of interleukin-1 receptor-associated kinase (IRAK1) gene polymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in a Chinese Han population Inflammation Research, March 13, 2013 Review Article
272 Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study Annals of Rheumatic Diseases, March 12, 2013 Clinical Article
273 Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort Annals of Rheumatic Diseases, March 12, 2013 Clinical Article
274 Cryptococcosis of lumbar vertebra in a patient with rheumatoid arthritis and scleroderma: case report and literature review Full Text BMC Infectious Diseases, March 12, 2013 Review Article
275 Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcets disease Annals of Rheumatic Diseases, March 11, 2013 Clinical Article
276 Back to the future: oral targeted therapy for RA and other autoimmune diseases Nature Reviews Rheumatology , March 11, 2013 Clinical Article
277 The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age Arthritis Research & Therapy, March 11, 2013 Clinical Article
278 Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients Annals of Rheumatic Diseases, March 11, 2013 Review Article
279 New insight on the Xq28 association with systemic sclerosis Annals of Rheumatic Diseases, March 8, 2013 Clinical Article
280 Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial The Journal of Rheumatology, March 8, 2013 Clinical Article
In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.
Read the article summaryIn a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.
Read the article summaryIn a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.
Read the article summaryIndexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close